Clinical Trial: A single-center, parallel-group, non-randomized controlled prospective study of efgartigimod administered at different cycles in patients with new-onset generalized myasthenia gravis (gMG) (China)

Posted On: 2026-10-09

China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-center, parallel-group, non-randomized controlled prospective study of efgartigimod administered at different cycles in patients with new-onset generalized myasthenia gravis (gMG)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133923

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: The First Hospital of China Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327224

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A single-center, parallel-group, non-randomized controlled prospective study of efgartigimod administered at different cycles in patients with new-onset generalized myasthenia gravis (gMG) (China)